GALT

NASDAQ · Equity

Galectin Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
2.520000
Fair value
2.531844
Expectation
Positive 57.19%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.52
12-Week Change
-18.45%
Trend Signal
Inactive
Expectation
Positive 57.19%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-42.34
Market Dynamics
-0.01

Over the latest 12 completed weeks ending 2026-05-29, GALT fell 18.45%, moving from 3.09 to 2.52. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -42.34 and has softened across the 12-week window. Market Dynamics is -0.01 on the latest week. Expectation is positive at 57.19%.